Yungang Biology

ABOUT

Company Profile

Yungang Biology

Changde Yungang Biotechnology Co., Ltd.


Changde Yungang Biotechnology Co., Ltd. (hereinafter referred to as "Yungang biological") was established in 2003. At present, it has two production bases, high-tech zone and economic and Technological Development Zone, and plans to build the largest comprehensive production and processing base of bold resources in China. The company covers an area of about 86666 square meters, has more than 300 employees, has a number of GMP standard production lines, has built its own R & D center and obtained the qualification of provincial bile acid technology platform, and has obtained nearly 20 invention patents related to bile acid products. The company has successively won the honorary titles of "National High-tech Enterprise", "National Specialized Special New Enterprise", "Hunan Small Giant Enterprise", "Hunan Agricultural Industrialization Leading Enterprise", "Hunan Provincial Enterprise Technology Center", "New Hunan contribution Award Advanced Collective" Unit, "Changde City Model harmonious Labor Relations Enterprise" and so on.

 

We always adhere to the mission of "focusing on biological resources and improving the quality of life", and always focus on the research and development and application of animal gallbladder resources technology. The main products are bile acid series and various animal bile active extracts. Around the industrial positioning, Yungang has successively developed a series of products such as chenodeoxycholic acid, ursodeoxycholic acid, bilirubin, bile salt, bile acid feeding, etc., and has been applied to drugs, microbial detection reagents, animal health care, etc. Among them, the market share of the main product "ursodeoxycholic acid intermediate" ranks first in the industry.

 

Companies adhering to the concept of innovation, self-built R & D center, focusing on "comprehensive development and utilization of bile", long-term cooperation with well-known research and development institutions at home and abroad, mainly engaged in animal bile resources technology research and development and application. There are more than 20 patents, including 14 domestic invention patents and 3 international invention patents, and have a number of independent intellectual property rights and scientific research achievements. Yungang biological industry project is one of the seven strategic emerging industries of the country. It is the three-year tackling action of "innovation breakthrough and industrial breakthrough" of Changde municipal Party committee and government, and focuses on supporting biomedical and big health industry. After the Deshan base is fully put into operation, Yungang Biology will form a matrix of three major industries: pharmaceuticals, animal protection and beauty makeup, and strive to build Yungang into a full industrial chain enterprise from raw materials to end-product production and sales.

2003

Established in

300 +

Existing staff

86666

Company occupies